The Role of Glycosylation in Autoimmune Disease

References

• Gahmberg C. G., Tolvanen M., Kotovuori P. Leukocyte adhesion – Structure and function of human leukocyte β-integrins and their cellular ligands. Eur. J. Biochem 1997; 245: 215–232
   PubMedGoogle Scholar
• Lawson J. H., Piatt J. L. Molecular barriers to xenotransplantation. Transplantation 1996; 62: 303–310
   PubMed Web of Science ®Google Scholar
• Raguputhi G. Carbohydrate antigens as targets for active specific immunotherapy. Cancer Immunol. Immunother 1996; 43: 152–157
   PubMed Web of Science ®Google Scholar
• Kreppel L. K., Blomberg M. A., Hart G. W. Dynamic glycosylation of nuclear and cytosolic proteins – Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J. Biol. Chem 1997; 272: 9308–9315
   PubMed Web of Science ®Google Scholar
• Chan P. Y., Lawrence M. B., Dustin M. L., Ferguson L. M., Golan D. E., Springer T. A. Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2. J. Cell. Biol 1991; 115: 245–55
   PubMed Web of Science ®Google Scholar
• Terry R. W., Kwee L., Levine J. F., Labow M. A. Cytokine induction of an alternatively spliced murine vascular cell adhesion molecule (VCAM) mRNA encoding a glycosylphosphatidylinositol-anchored VCAM protein. Proc. Natl. Acad. Sci. USA 1993; 90: 5919–5923
   PubMed Web of Science ®Google Scholar
• Brownlee M. Advanced protein glycosylation in diabetes and aging. Ann. Rev. Med. 1995; 46: 223–34
   PubMed Web of Science ®Google Scholar
• Natsuka S., Lowe J. B. Enzymes involved in mammalian oligosaccharide biosynthesis. Curr. Opin. Struct. Biol 1994; 4: 683–691
   Web of Science ®Google Scholar
• Paulson J. C., Colley K. J. Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J. Biol. Chem 1989; 264: 17615–17618
   PubMed Web of Science ®Google Scholar
• Baenziger J. U. Protein-specific glycosyltransfera-ses – how and why they do it!. FASEB J 1994; 8: 1019–1025
   PubMed Web of Science ®Google Scholar
• Sumar N. Analytical Methods 2: Lectins. bnormalities of IgG Glycosylation and Immunological Disorders, D. A. Isenberg, T. W. Rademacher. John Wiley and Sons, Chichester 1996; 65–87
   Google Scholar
• Wang Y., Rook G. A. W. Analytical Methods 3 Monoclonal antibodie. Abnormalities of IgG Glycosylation and Immunological Disorders, D. A. Isenberg, T. W. Rademacher. John Wiley and Sons, Chichester 1996; 89–99
   Google Scholar
• Jones R. H., Rademacher T. W., Williams P. J. Bias in murine IgG isotype immobilisation. Implications for IgG glycoform analysis ELISA procedures. J. Immunol. Methods 1996; 197: 109–120
   PubMed Web of Science ®Google Scholar
• Williams P. J. Analytical Methods 1: Biochemica. Abnormalities of IgG Glycosylation and Immunological Disorders, D. A. Isenberg, T. W. Rademacher. John Wiley and Sons, Chichester 1996; 45–64
   Google Scholar
• Tarentino A. L., Plummer T. H. Enzymatic deg-lycosylation of asparagine-linked glycans – purification, properties, and specificity of oligosaccharide-cleaving enzymes from fiavobacterium-meningosepticum. Methods Enzymol 1994; 230: 44–57
   PubMed Web of Science ®Google Scholar
• Stanley P., Raju T. S., Bhaumik M. CHO cells provide access to novel N-glycans and develop-mentally regulated glycosyltransferases. Glycobiology 1996; 6: 695–699
   PubMed Web of Science ®Google Scholar
• Zeng G., Ariga T., Gu X. B., Yu R. K. Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: effect on cellular differentiation. Proc. Natl. Acad. Sci. USA 1995; 92: 8670–8674
   PubMed Web of Science ®Google Scholar
• Prieto P. A., Mukerji P., Kelder B., Erney R., Gonzalez D., Yun J. S., et al. Remodeling of mouse milk glycoconjugates by transgenic expression of a human glycosyltransferas. J. Biol. Chem 1995; 270: 29515–29519
   PubMed Web of Science ®Google Scholar
• Asano M., Furukawa K., Kido M., Matsumoto S., Ume-Saki Y., Kochibe N., Iwakura Y. Growth retardation and early death of β-1, 4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells. EMBO J 1997; 16: 1850–1857
   PubMed Web of Science ®Google Scholar
• Lu Q., Hasty P., Shur B. D. Targeted mutation in β1, 4-galactosyltransferase leads to pituitary insufficiency and neonatal lethality. Dev. Biol 1997; 181: 257–267
   PubMed Web of Science ®Google Scholar
• Miller D. J., Gong X., Shur B. D. Sperm require beta-N-acetylglucosaminidase to penetrate through the egg zona pellucida. Development 1993; 118: 1279–1289
   PubMed Web of Science ®Google Scholar
• Wormald M. R., Rudd P. M., Harvey D. J., Chang S. C, Scragg I. G., Dwek R. A. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 1997; 36: 1370–1380
   PubMed Web of Science ®Google Scholar
• Jefferis R., Lund J. Glycosylation of antibody molecules: structural and functional significance. Chem. Immunol 1997; 65: 111–128
   PubMedGoogle Scholar
• Wright A., Morrison S. L. Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol 1997; 15: 26–32
   PubMed Web of Science ®Google Scholar
• Garcia K. C, Degano M., Stanfield R. L., Brunmark A., Jackson M. R., Peterson P. A., et al. An αβ T cell receptor structure at 2.5 å and its orientation in the TCR-MHC complex. Science 1996; 274: 209–219
   PubMed Web of Science ®Google Scholar
• Dietrich J., Neisig A., Hou X., Wegener A. M., Gajhede M., Geisler C. Role of CD3 gamma in T cell receptor assembly. J. Cell. Biol 1996; 132: 299–310
   PubMed Web of Science ®Google Scholar
• Ishikawa S., Kowal C, Cole B., Thomson C., Diamond B. Replacement of N-glycosylation sites on the MHC class II E α chain. Effect on thymic selection and peripheral T cell activation. J. Immunol 1995; 154: 5023–5029
   PubMed Web of Science ®Google Scholar
• Shen L., Kane K. P. Differential ability of isolated H-2 Kb subsets to serve as TCR ligands for allo-specific CTL clones; potential role for N-linked glycosylation. J. Exp. Med. 1995; 181: 1773–1783
   PubMed Web of Science ®Google Scholar
• Etzioni A., Frydman M., Pollack S., Avidor I., Phillips M. L., Paulson J. C., Gershoni-Baruch R. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N. Engl. J. Med. 1992; 327: 1789–1792
   PubMed Web of Science ®Google Scholar
• Maly P., Thall A., Petryniak B., Rogers C. E., Smith P. L., Marks R. M., et al. The α(1, 3)fucosyltrans-ferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 1996; 86: 643–653
   PubMed Web of Science ®Google Scholar
• Higgins E. A., Siminovitch K. A., Zhuang D. L., Brockhausen I., Dennis J. W. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J. Biol Chem 1991; 266: 6280–6290
   PubMed Web of Science ®Google Scholar
• Piller F., Le Deist F., Weinberg K. I., Parkman R., Fukuda M. Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome. J. Exp. Med. 1991; 173: 1501–1510
   PubMed Web of Science ®Google Scholar
• Ellies L. G., Tao W., Fellinger W., The H. S., Ziltener H. J. The CD43 130-kD peripheral T-cell activation antigen is downregulated in thymic positive selection. Blood 1996; 88: 1725–1732
   PubMed Web of Science ®Google Scholar
• Bennett K. L., Modrell B., Greenfield B., Bartolazzi A., Stamenkovic I., Peach R., et al. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol 1995; 131: 1623–1633
   PubMed Web of Science ®Google Scholar
• Perillo N. L., Pace K. E., Seilhamer J. J., Baum L. G. Apoptosis of T cells mediated by galectin-1. Nature 1995; 378: 736–739
   PubMed Web of Science ®Google Scholar
• Yang R. Y., Hsu D. K., Liu F. T. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc. Natl. Acad. Sci. USA. 1996; 93: 6737–6742
   PubMed Web of Science ®Google Scholar
• Singhal A., Hakomori S. I. Molecular changes in carbohydrate antigens associated with cancer. BioEssays 1990; 12: 223–230
   PubMed Web of Science ®Google Scholar
• Mullinax F., Mullinax G. L. Abnormality of IgG structure in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1975; 18: 417–418
   Google Scholar
• Parekh R. B., Dwek R. A., Sutton B. J., Fernandes D. L., Leung A., Stanworth D., et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316: 452–457
   PubMed Web of Science ®Google Scholar
• Tomana M., Schrohenloher R. E., Koopman W. J., Alarcon G. S., Paul W. A. Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum 1988; 31: 333–338
   PubMed Web of Science ®Google Scholar
• Tsuchiya N., Endo T., Matsuta K., Yoshinoya S., Takeuchi F., Nagano Y., et al. Detection of glycosylation abnormality in rheumatoid IgG using N-acetylgluco-samine-specific Psathyrella velutina lectin. J. Immunol 1993; 151: 1137–1146
   PubMed Web of Science ®Google Scholar
• van-Zeben D., Hazes J. M, Zwinderman A. H., Vanden-Broucke J. P., Breedveld F. C. Factors predicting outcome of rheumatoid arthritis: results of a followup study. J. Rheumatol 1993; 20: 1288–1296
   PubMed Web of Science ®Google Scholar
• Bond A., Alavi A., Axford J. S., Bourke B. E., Bruckner F. E., Kerr M. A., Maxwell J. D., Tweed K. J., Wel-Don M. J., Youinou P., Hay F. C. A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamin. J. Autoimmun 1997; 10: 77–85
   PubMed Web of Science ®Google Scholar
• Bond A., Cooke A., Hay F. C. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis. Eur. J. Immunol 1990; 20: 2229–2233
   PubMed Web of Science ®Google Scholar
• Thompson S. J., Hitsumoto Y., Zhang Y. W., Rook G. A., Elson C. J. Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG. Clin. Exp. Immunol 1992; 89: 434–438
   PubMed Web of Science ®Google Scholar
• McCulloch J., Zhang Y. W., Dawson M., Harkiss G. D., Peterhans E., Vogt H. R., et al. Glycosylation of IgG during potentially arthritogenic lentiviral infections. Rheumatol. Int. 1995; 14: 243–248
   PubMed Web of Science ®Google Scholar
• Williams P. J., Rademacher T. W. Analysis of murine IgG isotype galactosylation in collagen-induced arthritis. Scand. J. Immunol 1996; 44: 381–387
   PubMed Web of Science ®Google Scholar
• Rademacher T. W., Williams P., Dwek R. A. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. USA 1994; 91: 6123–6127
   PubMed Web of Science ®Google Scholar
• Tsuchiya N., Endo T., Matsuta K., Yoshinoya S., Aikawa T., Kosuge E., Takeuchi F., Miyamoto T., Kobata A. Effects of galactose depletion from oligosaccharide chains on immunoglobulin activities of human IgG. J. Rheumatol 1989; 16: 285–290
   PubMed Web of Science ®Google Scholar
• Lund J., Takahashi N., Pound J. D., Goodall M., Jefferis R. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains. J. Immunol 1996; 157: 4963–4969
   PubMed Web of Science ®Google Scholar
• Malhotra R., Wormald M. R., Rudd P. M, Fischer P. B., Dwek R. A., Sim R. B. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1995; 1: 237–243
   PubMed Web of Science ®Google Scholar
• Cuchacovich M., Gatica H., Grigg D. M., Pizzo S. V., Gonzalez-Gronow M. Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and tibronectin in the serum of patients with rheumatoid arthritis. J. Rheumatol 1996; 23: 44–51
   PubMed Web of Science ®Google Scholar
• White K. D., Cummings R. D., Waxman F. J. Ig N-glycan orientation can influence interactions with the complement system. J. Immunol 1997; 158: 426–435
   PubMed Web of Science ®Google Scholar
• Adler Y., Lamour A., Jamin C., Menez J. F., LeCorre R., Shoenfeld Y., Youinou P. Impaired binding capacity of asialyl and agalactosyl IgG to Fe gamma receptors. Clin. Exp. Rheumatol 1995; 13: 315–319
   PubMed Web of Science ®Google Scholar
• Newkirk M. M., Novick J., Stevenson M. M., Fournicr M. J., Apostolakos P. Differential clearance of glycoforms of IgG in normal and autoimmune-prone mice. Clin. Exp. Immunol 1996; 106: 259–264
   PubMed Web of Science ®Google Scholar
• Groenink J., Spijker J., van den Herik-Oudijk I. E., Boeije L., Rook G., Aarden L., et al. On the interaction between agalactosyl IgG and Fc gamma receptors. Eur. J. Immunol 1996; 26: 1404–1407
   PubMed Web of Science ®Google Scholar
• Soltys A. J., Hay F. C., Bond A., Axford J. S., Jones M. G., Randen I., Thompson K. M., Natvig J. B. The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand. J. Immunol 1994; 40: 135–143
   PubMed Web of Science ®Google Scholar
• Corper A. L., Sohi M. K., Bonagura V. R., Steinitz M., Jefferis R., Feinstein A., Beale D., Taussig M. J., Sutton B. J. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nature Struct. Biol 1997; 4: 374–381
   PubMedGoogle Scholar
• Bodman-Smith K., Sumar N., Sinclair H., Roitt I., Isen-Berg D., Young A. Agalactosyl IgG[Gal(o)] – an analysis of its clinical utility in the long-term follow-up of patients with rheumatoid arthritis. Br. J. Rheumatol 1996; 35: 1063–1066
   PubMedGoogle Scholar
• Bond A., Kerr M. A., Hay F. C. Distinct oligosaccharide content of rheumatoid arthritis-derived immune complexes. Arthritis Rheum 1995; 38: 744–49
   PubMed Web of Science ®Google Scholar
• Axford J. S., Lydyard P. M., Isenberg D. A., MacKenzie L., Hay F. C., Roitt I. M. Reduced B-cell galactosyltransferase activity in rheumatoid-arthritis. Lancet 1987; ii: 1486–1488
   Google Scholar
• Wilson I. B., Platt F. M., Isenberg D. A., Rademacher T. W. Aberrant control of galactosyltransferase in peripheral B lymphocytes and Epstein-Barr virus transformed B lymphoblasts from patients with rheumatoid arthritis. J. Rheumatol 1993; 20: 1282–1287
   PubMed Web of Science ®Google Scholar
• Furukawa K., Matsuta K., Takeuchi F., Kosuge E., Miyamoto T., Kobata A. Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis. Int. Immunol 1990; 2: 105–112
   PubMed Web of Science ®Google Scholar
• Keusch J., Isenberg P. M., Lydyard D. A., Delves P. J. β1, 4-Galactosyltransferase activity in B cells detected using a simple ELISA-based assay. Glycobiology 1995; 5: 365–370
   PubMed Web of Science ®Google Scholar
• Rumpel B. M., Rademacher T. W., Rook G. A., Williams P. J., Wilson I. B. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. Hum. Antibodies Hvbridomas 1994; 5: 143–151
   PubMedGoogle Scholar
• Delves P. J., Kidd V. J. The glycosyltrans-ferase genes. Abnormalities of IgG Glycosylation and Immunological Disorders, D. A. Isenberg, T. W. Rademacher. John Wiley and Sons, Chichester 1996; 171–199
   Google Scholar
• Uehara K., Muramatsu T. Molecular cloning and characterization of β-1, 4-galactosyltransferase expressed in mouse testis. Eur. J. Biochem 1997; 244: 706–712
   PubMedGoogle Scholar
• Pilkington C, Taylor P. V., Silverman E., Isenberg D. A., Del Costello A. M., Rook G. A. W. Agalactosyl IgG and materno-fetal transmission of autoimmune neonatal lupus. Rheumatol. International 1996; 16: 89–94
   PubMed Web of Science ®Google Scholar
• Allen A. C, Harper S. J., Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgAl and IgG in IgA nephropathy. Clin. Exp. Immunol 1995; 100: 470–474
   PubMed Web of Science ®Google Scholar
• Allen A. C, Topham P. S., Harper S. J., Feehally J. Leucocyte, β1, 3 galactosyltransferase activity in IgA nephropathy. Nephrol. Dial. Transplant 1997; 12: 701–706
   PubMed Web of Science ®Google Scholar
• Hiki Y., Iwase H., Kokubo T., Horii A., Tanaka A., Nishikido J., Hotta K., Kobayashi Y. Association of asialogalactosyl β1–3.N-acetylgalactosamineon the hinge with a conformational instability of Jacalin-reactive immunoglobulin AI in immunoglobulin A nephropathy. J. Am. Soc. Nephrol 1996; 7: 955–960
   PubMed Web of Science ®Google Scholar
• Tomana M., Matousovic K., Julian B. A., Radl J., Ko-Necny K., Mestecky J. Galactose-deficientlgAl in sera of IgA nephropathy patients is present in complexes with IgG. Kidney. Int. 1997; 52: 509–516
   PubMed Web of Science ®Google Scholar
• Hadley A. G., Zupanska B., KumpeI B. M., Pilkington C, Griffiths H. L., Leader K. A., et al. The glycosylation of red cell autoantibodies affects their functional activity in vitro. Br. J. Haematol 1995; 91: 587–594
   PubMed Web of Science ®Google Scholar
• Lefebvre J. C, Giordanengo V., Limouse M., Doglio A., Cucchiarini M., Monpoux F., et al. Altered glyco-sylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line. J. Exp. Med. 1994; 180: 1609–1617
   PubMed Web of Science ®Google Scholar
• Giordanengo V., Limouse M., Desroys du Roure L., Cottalorda J., Doglio A., Passeron A., et al. Autoantibodies directed against CD43 molecules with an altered glycosylation status on human immunodeficiency virus type 1 (HIV-1)-infected CEM cells are found in all HIV-1+ individuals. Blood 1995; 86: 2302–2311
   PubMed Web of Science ®Google Scholar
• Rapoport B., McLachlan S. M., Kakinuma A., Chazenbalk G. D. Critical relationship between autoantibody recognition and thyrotropin receptor maturation as reflected in the acquisition of complex carbohydrate. J. Clin. Endocrinol. Metab 1996; 81: 2525–2533
   PubMed Web of Science ®Google Scholar
• Seetharamaiah G. S., Dallas J. S., Patibandla S. A., Thotakura N. R., Prabhakar B. S. Requirement of glycosylation of the human thyrotropin receptor ectodomain for its reactivity with autoantibodies in patients' sera. J. Immunol 1997; 158: 2798–2804
   PubMed Web of Science ®Google Scholar
• Galili U. Abnormal expression of α-galactosyl epitopes in man. A trigger for autoimmune processes. Lancet 1989; 2: 358–361
   PubMed Web of Science ®Google Scholar
• Winand R. J., Devigne J. W., Mourisse M., Galili U. Specific stimulation of Graves' disease thyrocytes by the natural anti-gal antibody from normal and autologous serum. J. Immunol 1994; 153: 1386–1395
   PubMed Web of Science ®Google Scholar
• Roitt I. M., Pujol-Borrell R., Hanafusa T., Delves P. J., Bottazzo G. F., Kohn L. D. Asialoagalactothy-roglobulin binds to the surface of human thyroid cells at a site distinct from the 'microsomal' autoantigen. Clin. Exp. Immunol 1984; 56: 129–134
   PubMed Web of Science ®Google Scholar
• Hafer-Macko C, Pang M., Seilhamer J. J., Baum L. G. Galectin-1 is expressed by thymic epithelial cells in myasthenia gravis. Glvcoconj. J. 1996; 13: 591–597
   PubMed Web of Science ®Google Scholar
• Bodman K. B., Hutchings P. R., Jeddi P. A., Delves P. J., Rook G. A., Sumar N., et al. IgG glycosylation in autoimmune-prone strains of mice. Clin. Exp. Immunol 1994; 95: 103–107
   PubMed Web of Science ®Google Scholar
• Delves P. J., Jeddi P. A., Bodman K., Sumar N., Lund T., Pouncey L., et al. Genes and IgG glycosylation in autoimmune and non-autoimmune strains of mice. Ann. Rheum. Dis. 1992; 51: 1275–1276
   Google Scholar
• Mackiewicz A., Schultz D., Mathison J., Ganapathi M., Kushner I. Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines. Clin. Exp. Immunol 1989; 75: 70–75
   PubMed Web of Science ®Google Scholar